Axsome Therapeutics, Inc. (AXSM)
204.22
-2.93
(-1.41%)
USD |
NASDAQ |
Aug 27, 11:32
Axsome Therapeutics Total Assets (Quarterly) : 761.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 761.45M |
| March 31, 2026 | 713.61M |
| December 31, 2025 | 689.80M |
| September 30, 2025 | 669.25M |
| June 30, 2025 | 639.78M |
| March 31, 2025 | 596.67M |
| December 31, 2024 | 568.50M |
| September 30, 2024 | 561.46M |
| June 30, 2024 | 548.23M |
| March 31, 2024 | 545.73M |
| December 31, 2023 | 588.24M |
| September 30, 2023 | 600.86M |
| June 30, 2023 | 611.64M |
| March 31, 2023 | 389.18M |
| December 31, 2022 | 331.48M |
| September 30, 2022 | 338.96M |
| June 30, 2022 | 180.56M |
| March 31, 2022 | 88.56M |
| December 31, 2021 | 87.79M |
| September 30, 2021 | 116.60M |
| June 30, 2021 | 143.26M |
| March 31, 2021 | 166.90M |
| Date | Value |
|---|---|
| December 31, 2020 | 186.13M |
| September 30, 2020 | 203.63M |
| June 30, 2020 | 190.99M |
| March 31, 2020 | 197.80M |
| December 31, 2019 | 220.55M |
| September 30, 2019 | 44.44M |
| June 30, 2019 | 54.78M |
| March 31, 2019 | 43.90M |
| December 31, 2018 | 15.38M |
| September 30, 2018 | 16.13M |
| June 30, 2018 | 21.73M |
| March 31, 2018 | 27.94M |
| December 31, 2017 | 35.56M |
| September 30, 2017 | 32.62M |
| June 30, 2017 | 39.04M |
| March 31, 2017 | 46.41M |
| December 31, 2016 | 38.21M |
| September 30, 2016 | 34.92M |
| June 30, 2016 | 40.01M |
| March 31, 2016 | 45.15M |
| December 31, 2015 | 49.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Liquidia Corp. | 521.92M |
| Filana Therapeutics, Inc. | 103.90M |
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 678.14M |
| Shareholders Equity (Quarterly) | 83.30M |
| Debt to Equity Ratio | 2.697 |
| Current Ratio | 1.426 |
| Net Debt Paydown Yield | -0.02% |